phosphoserine has been researched along with everolimus in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bedja, D; Chen, A; Dunkerly-Eyring, BL; Holewinski, RJ; Kass, DA; Kokkonen-Simon, KM; Lee, DI; Nakamura, T; Oeing, CU; Patel, CH; Powell, JD; Ranek, MJ; Sasaki, M; Van Eyk, JE; Vera, MP; Zhu, G | 1 |
1 other study(ies) available for phosphoserine and everolimus
Article | Year |
---|---|
PKG1-modified TSC2 regulates mTORC1 activity to counter adverse cardiac stress.
Topics: Animals; Autophagy; Cells, Cultured; Cyclic GMP-Dependent Protein Kinases; Disease Progression; Enzyme Activation; Everolimus; Female; Gene Knock-In Techniques; Heart Diseases; HEK293 Cells; Humans; Hypertrophy; Male; Mechanistic Target of Rapamycin Complex 1; Mice; Mutation; Myocytes, Cardiac; Phosphorylation; Phosphoserine; Pressure; Rats; Rats, Wistar; Serine; Tuberous Sclerosis Complex 2 Protein | 2019 |